T. Rowe Price Investment Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,032,392
Closed -$33.1M 796
2026
Q1
$33.1M Sell
2,032,392
-794,595
-28% -$12.4M 0.02% 408
2025
Q4
$42M Sell
2,826,987
-32,103
-1% -$454K 0.03% 396
2025
Q3
$36.7M Sell
2,859,090
-741,683
-21% -$9.88M 0.02% 423
2025
Q2
$54.7M Sell
3,600,773
-429,171
-11% -$6.7M 0.03% 377
2025
Q1
$67.3M Sell
4,029,944
-389,195
-9% -$7.16M 0.04% 343
2024
Q4
$83.3M Sell
4,419,139
-7,228,022
-62% -$139M 0.05% 324
2024
Q3
$219M Buy
11,647,161
+608,037
+6% +$11.6M 0.13% 176
2024
Q2
$209M Buy
11,039,124
+528,158
+5% +$9.01M 0.13% 173
2024
Q1
$171M Sell
10,510,966
-559,343
-5% -$8.19M 0.1% 214
2023
Q4
$140M Sell
11,070,309
-285,267
-3% -$3.6M 0.09% 228
2023
Q3
$155M Sell
11,355,576
-85,010
-0.7% -$1.31M 0.11% 210
2023
Q2
$196M Sell
11,440,586
-958,856
-8% -$14.9M 0.13% 177
2023
Q1
$173M Buy
12,399,442
+131,540
+1% +$1.94M 0.12% 175
2022
Q4
$164M Buy
12,267,902
+428,530
+4% +$5.54M 0.13% 178
2022
Q3
$141M Buy
+11,839,372
New +$168M 0.11% 185

Other funds holding SEM

T. Rowe Price Investment Management's SEM Position: Q2 2026 in Review

T. Rowe Price Investment Management sold out of Select Medical (SEM) in Q2 2026, closing a stake of 2,032,392 shares — an estimated $33.1M sold.

T. Rowe Price Investment Management first reported a position in SEM in Q3 2022 and held it in 15 quarters. The position peaked at $219M in Q3 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • T. Rowe Price Investment Management reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 2,032,392 Select Medical shares in Q2 2026, an estimated $33.1M.
  • T. Rowe Price Investment Management first reported a position in Select Medical in Q3 2022 and held it in 15 quarters.
  • T. Rowe Price Investment Management's Select Medical position peaked at $219M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.